Top ▲
GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
Target id: 1615
Nomenclature: Endothelin-converting enzyme 1
Abbreviated Name: ECE1
Family: M13: Neprilysin
Gene and Protein Information ![]() |
||||||
| Species | TM | AA | Chromosomal Location | Gene Symbol | Gene Name | Reference |
| Human | 1 | 770 | 1p36.12 | ECE1 | endothelin converting enzyme 1 | |
| Mouse | 1 | 769 | 4 D3 | Ece1 | endothelin converting enzyme 1 | |
| Rat | 1 | 762 | 5q36 | Ece1 | endothelin converting enzyme 1 | |
Previous and Unofficial Names ![]() |
| ECE-1 | ECE |
Database Links ![]() |
|
| Specialist databases | |
| MEROPS | M13.002 (Hs) |
| Other databases | |
| Alphafold | P42892 (Hs), Q4PZA2 (Mm), P42893 (Rn) |
| BRENDA | 3.4.24.71 |
| CATH/Gene3D | 3.40.390.10 |
| ChEMBL Target | CHEMBL4791 (Hs), CHEMBL2676 (Rn) |
| Ensembl Gene | ENSG00000117298 (Hs), ENSMUSG00000057530 (Mm), ENSRNOG00000014241 (Rn) |
| Entrez Gene | 1889 (Hs), 230857 (Mm), 94204 (Rn) |
| Human Protein Atlas | ENSG00000117298 (Hs) |
| KEGG Enzyme | 3.4.24.71 |
| KEGG Gene | hsa:1889 (Hs), mmu:230857 (Mm), rno:94204 (Rn) |
| OMIM | 600423 (Hs) |
| Orphanet | ORPHA121255 (Hs) |
| Pharos | P42892 (Hs) |
| RefSeq Nucleotide | NM_001113348 (Hs), NM_001113347 (Hs), NM_001113349 (Hs), NM_001397 (Hs), NM_199307 (Mm), NM_053596 (Rn) |
| RefSeq Protein | NP_001388 (Hs), NP_001106820 (Hs), NP_001106819 (Hs), NP_001106818 (Hs), NP_955011 (Mm), NP_446048 (Rn) |
| UniProtKB | P42892 (Hs), Q4PZA2 (Mm), P42893 (Rn) |
| Wikipedia | ECE1 (Hs) |
Enzyme Reaction ![]() |
||||
|
||||
| Endogenous substrates (Human) |
| endothelin-1 (EDN1, P05305), endothelin-2 (EDN2, P20800), endothelin-3 (EDN3, P14138) |
Download all structure-activity data for this target as a CSV file
| Inhibitors | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Key to terms and symbols | View all chemical structures | Click column headers to sort | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| View species-specific inhibitor tables | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Clinically-Relevant Mutations and Pathophysiology
|
||||||||||
|
||||||||||
|
||||||||||
1. Ahn K, et al. (1996) Quinazolines as inhibitors of endothelin converting enzyme. Patent number: WO1996019474. Assignee: Warner Lambert. Priority date: 22/12/1994. Publication date: 22/06/1996.
2. Jullien N, Makritis A, Georgiadis D, Beau F, Yiotakis A, Dive V. (2010) Phosphinic tripeptides as dual angiotensin-converting enzyme C-domain and endothelin-converting enzyme-1 inhibitors. J Med Chem, 53 (1): 208-20. [PMID:19899765]
3. Seed A, Kuc RE, Maguire JJ, Hillier C, Johnston F, Essers H, de Voogd HJ, McMurray J, Davenport AP. (2012) The dual endothelin converting enzyme/neutral endopeptidase inhibitor SLV-306 (daglutril), inhibits systemic conversion of big endothelin-1 in humans. Life Sci, 91 (13-14): 743-8. [PMID:22480515]
4. Umekawa K, Hasegawa H, Tsutsumi Y, Sato K, Matsumura Y, Ohashi N. (2000) Pharmacological characterization of a novel sulfonylureid-pyrazole derivative, SM-19712, a potent nonpeptidic inhibitor of endothelin converting enzyme. Jpn J Pharmacol, 84 (1): 7-15. [PMID:11043447]
M13: Neprilysin: Endothelin-converting enzyme 1. Last modified on 21/07/2015. Accessed on 26/10/2025. IUPHAR/BPS Guide to PHARMACOLOGY, https://www.guidetomalariapharmacology.org/GRAC/ObjectDisplayForward?objectId=1615.